Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lung Transplantation | 129 | 2024 | 1271 | 18.050 |
Why?
|
Cystic Fibrosis | 48 | 2024 | 1252 | 6.040 |
Why?
|
Bronchiolitis Obliterans | 15 | 2020 | 206 | 3.670 |
Why?
|
Heart-Lung Transplantation | 16 | 2022 | 84 | 3.640 |
Why?
|
Photopheresis | 7 | 2024 | 33 | 3.590 |
Why?
|
Primary Graft Dysfunction | 7 | 2018 | 104 | 3.140 |
Why?
|
Lung Diseases | 22 | 2020 | 1894 | 2.740 |
Why?
|
Organ Transplantation | 12 | 2024 | 1130 | 2.210 |
Why?
|
Waiting Lists | 13 | 2023 | 716 | 2.000 |
Why?
|
Graft Rejection | 40 | 2024 | 4203 | 1.900 |
Why?
|
Switzerland | 27 | 2022 | 309 | 1.890 |
Why?
|
Tissue and Organ Procurement | 10 | 2023 | 889 | 1.570 |
Why?
|
Tissue Donors | 27 | 2023 | 2206 | 1.410 |
Why?
|
Heart Transplantation | 17 | 2022 | 3032 | 1.320 |
Why?
|
Registries | 24 | 2019 | 8170 | 1.300 |
Why?
|
Hypertension, Pulmonary | 7 | 2018 | 1541 | 0.910 |
Why?
|
Transplantation | 8 | 2013 | 217 | 0.860 |
Why?
|
Postoperative Complications | 20 | 2019 | 15341 | 0.770 |
Why?
|
Hyperammonemia | 1 | 2020 | 75 | 0.680 |
Why?
|
Child | 56 | 2024 | 78469 | 0.660 |
Why?
|
Immunosuppressive Agents | 22 | 2024 | 4055 | 0.660 |
Why?
|
Lung | 21 | 2022 | 9843 | 0.630 |
Why?
|
Oseltamivir | 2 | 2019 | 76 | 0.620 |
Why?
|
Scedosporium | 1 | 2017 | 10 | 0.610 |
Why?
|
Lymphoproliferative Disorders | 2 | 2016 | 532 | 0.600 |
Why?
|
Benzodioxoles | 1 | 2018 | 74 | 0.590 |
Why?
|
Aminophenols | 1 | 2018 | 84 | 0.580 |
Why?
|
Mycoses | 2 | 2017 | 383 | 0.580 |
Why?
|
Communicable Disease Control | 2 | 2020 | 841 | 0.570 |
Why?
|
Lymphatic Irradiation | 1 | 2017 | 113 | 0.570 |
Why?
|
Exercise | 4 | 2021 | 5687 | 0.560 |
Why?
|
Graft Survival | 16 | 2024 | 3599 | 0.560 |
Why?
|
Gram-Negative Bacterial Infections | 2 | 2016 | 235 | 0.550 |
Why?
|
Immunomodulation | 1 | 2020 | 540 | 0.550 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 3 | 2019 | 442 | 0.540 |
Why?
|
Retrospective Studies | 55 | 2024 | 78293 | 0.530 |
Why?
|
Humans | 171 | 2024 | 746070 | 0.530 |
Why?
|
Respiratory Insufficiency | 4 | 2020 | 1210 | 0.530 |
Why?
|
Adolescent | 56 | 2021 | 86212 | 0.520 |
Why?
|
Antibodies | 1 | 2024 | 2408 | 0.520 |
Why?
|
Spiroplasma | 1 | 2015 | 4 | 0.520 |
Why?
|
Exercise Test | 7 | 2024 | 2082 | 0.500 |
Why?
|
International Agencies | 4 | 2015 | 244 | 0.490 |
Why?
|
Child, Preschool | 26 | 2023 | 41383 | 0.480 |
Why?
|
Lung Diseases, Interstitial | 3 | 2018 | 864 | 0.480 |
Why?
|
Kaplan-Meier Estimate | 23 | 2019 | 6453 | 0.480 |
Why?
|
Quinolones | 1 | 2018 | 375 | 0.480 |
Why?
|
Forced Expiratory Volume | 10 | 2018 | 1789 | 0.470 |
Why?
|
Idiopathic Pulmonary Fibrosis | 3 | 2017 | 478 | 0.460 |
Why?
|
Aminopyridines | 1 | 2018 | 560 | 0.460 |
Why?
|
Bronchoalveolar Lavage Fluid | 6 | 2019 | 745 | 0.450 |
Why?
|
Adult | 81 | 2024 | 214969 | 0.450 |
Why?
|
Survival Rate | 18 | 2022 | 12632 | 0.440 |
Why?
|
Quality of Life | 14 | 2020 | 12985 | 0.440 |
Why?
|
Extracorporeal Membrane Oxygenation | 5 | 2016 | 1396 | 0.430 |
Why?
|
Bronchiectasis | 1 | 2014 | 133 | 0.430 |
Why?
|
Hepatitis | 1 | 2015 | 230 | 0.430 |
Why?
|
Brain Death | 4 | 2022 | 340 | 0.420 |
Why?
|
Transplantation Immunology | 2 | 2017 | 509 | 0.420 |
Why?
|
Preoperative Care | 2 | 2015 | 2218 | 0.420 |
Why?
|
Infant | 23 | 2020 | 35448 | 0.420 |
Why?
|
Influenza, Human | 4 | 2020 | 1502 | 0.410 |
Why?
|
Female | 98 | 2021 | 382129 | 0.410 |
Why?
|
Respiratory Tract Infections | 5 | 2020 | 985 | 0.410 |
Why?
|
Societies, Medical | 10 | 2016 | 3790 | 0.400 |
Why?
|
Donor Selection | 3 | 2018 | 203 | 0.400 |
Why?
|
Heart Diseases | 6 | 2017 | 2764 | 0.400 |
Why?
|
Male | 94 | 2022 | 351098 | 0.400 |
Why?
|
Young Adult | 41 | 2021 | 57114 | 0.390 |
Why?
|
Anti-Bacterial Agents | 10 | 2018 | 7223 | 0.370 |
Why?
|
Immunocompromised Host | 2 | 2017 | 846 | 0.370 |
Why?
|
Breathing Exercises | 1 | 2010 | 58 | 0.360 |
Why?
|
Europe | 7 | 2020 | 3354 | 0.350 |
Why?
|
Transplantation, Homologous | 9 | 2022 | 4617 | 0.350 |
Why?
|
Respiratory Muscles | 1 | 2010 | 141 | 0.350 |
Why?
|
Lymphangiosarcoma | 1 | 2009 | 14 | 0.330 |
Why?
|
Treatment Outcome | 34 | 2020 | 63664 | 0.330 |
Why?
|
Antiviral Agents | 4 | 2019 | 3013 | 0.330 |
Why?
|
Thinness | 1 | 2012 | 488 | 0.330 |
Why?
|
Clarithromycin | 1 | 2009 | 85 | 0.330 |
Why?
|
Severity of Illness Index | 10 | 2020 | 15539 | 0.320 |
Why?
|
Pandemics | 5 | 2022 | 8434 | 0.320 |
Why?
|
Exhalation | 3 | 2018 | 180 | 0.310 |
Why?
|
Dyslipidemias | 1 | 2015 | 875 | 0.310 |
Why?
|
Consensus | 4 | 2020 | 3011 | 0.310 |
Why?
|
Pulmonary Diffusing Capacity | 2 | 2018 | 95 | 0.300 |
Why?
|
Antifungal Agents | 3 | 2017 | 706 | 0.300 |
Why?
|
Age Factors | 15 | 2020 | 18145 | 0.280 |
Why?
|
Postoperative Care | 3 | 2013 | 1463 | 0.270 |
Why?
|
Standard of Care | 2 | 2020 | 547 | 0.270 |
Why?
|
Patient Selection | 7 | 2016 | 4192 | 0.270 |
Why?
|
Middle Aged | 57 | 2021 | 214419 | 0.270 |
Why?
|
Ceftazidime | 1 | 2006 | 51 | 0.270 |
Why?
|
Infection Control | 2 | 2017 | 972 | 0.270 |
Why?
|
Airway Remodeling | 2 | 2017 | 132 | 0.260 |
Why?
|
Respiratory Therapy | 2 | 2018 | 127 | 0.260 |
Why?
|
Sputum | 2 | 2018 | 489 | 0.260 |
Why?
|
Airway Management | 2 | 2020 | 320 | 0.260 |
Why?
|
Bronchoalveolar Lavage | 3 | 2020 | 128 | 0.250 |
Why?
|
Vaccination | 3 | 2022 | 3282 | 0.250 |
Why?
|
Bacterial Infections | 2 | 2014 | 1395 | 0.250 |
Why?
|
Lung Diseases, Fungal | 2 | 2017 | 125 | 0.250 |
Why?
|
Prognosis | 12 | 2024 | 29072 | 0.250 |
Why?
|
Gentamicins | 1 | 2006 | 250 | 0.250 |
Why?
|
Lipids | 1 | 2015 | 3290 | 0.240 |
Why?
|
Risk Factors | 31 | 2019 | 72413 | 0.240 |
Why?
|
Immune Tolerance | 2 | 2012 | 2215 | 0.240 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2017 | 3984 | 0.240 |
Why?
|
Follow-Up Studies | 17 | 2021 | 38752 | 0.230 |
Why?
|
Breath Tests | 2 | 2018 | 291 | 0.220 |
Why?
|
Coronary Angiography | 1 | 2015 | 4514 | 0.210 |
Why?
|
Reoperation | 9 | 2018 | 4215 | 0.210 |
Why?
|
Bronchoscopy | 2 | 2019 | 887 | 0.210 |
Why?
|
Respiratory Function Tests | 7 | 2018 | 1666 | 0.210 |
Why?
|
Seasons | 3 | 2020 | 1505 | 0.200 |
Why?
|
Viral Load | 2 | 2014 | 3297 | 0.200 |
Why?
|
Pulmonary Alveoli | 2 | 2017 | 649 | 0.190 |
Why?
|
Nitric Oxide | 3 | 2017 | 2121 | 0.170 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2024 | 1420 | 0.170 |
Why?
|
Diatrizoate Meglumine | 1 | 2019 | 79 | 0.170 |
Why?
|
Body Mass Index | 4 | 2019 | 12633 | 0.170 |
Why?
|
Postoperative Period | 3 | 2020 | 1804 | 0.160 |
Why?
|
Delayed Graft Function | 1 | 2019 | 44 | 0.160 |
Why?
|
Survival Analysis | 9 | 2017 | 10127 | 0.160 |
Why?
|
Lung Neoplasms | 2 | 2017 | 13196 | 0.160 |
Why?
|
Ventricular Function | 1 | 2020 | 408 | 0.160 |
Why?
|
Time Factors | 14 | 2019 | 39589 | 0.160 |
Why?
|
Chest Wall Oscillation | 1 | 2018 | 15 | 0.160 |
Why?
|
Exercise Tolerance | 3 | 2019 | 788 | 0.160 |
Why?
|
Multivariate Analysis | 8 | 2019 | 12018 | 0.160 |
Why?
|
Exocrine Pancreatic Insufficiency | 1 | 2019 | 84 | 0.150 |
Why?
|
Risk Assessment | 6 | 2020 | 23454 | 0.150 |
Why?
|
Mycetoma | 1 | 2017 | 14 | 0.150 |
Why?
|
Gastroesophageal Reflux | 1 | 2005 | 803 | 0.150 |
Why?
|
RNA Virus Infections | 1 | 2017 | 18 | 0.150 |
Why?
|
DNA Virus Infections | 1 | 2017 | 15 | 0.150 |
Why?
|
Comorbidity | 5 | 2020 | 10348 | 0.150 |
Why?
|
Proportional Hazards Models | 10 | 2018 | 12272 | 0.150 |
Why?
|
Virus Shedding | 2 | 2016 | 107 | 0.150 |
Why?
|
Research Report | 4 | 2012 | 359 | 0.150 |
Why?
|
Forecasting | 2 | 2021 | 2906 | 0.140 |
Why?
|
Hyperthyroidism | 1 | 2019 | 292 | 0.140 |
Why?
|
Ribavirin | 2 | 2016 | 394 | 0.140 |
Why?
|
Employment | 2 | 2020 | 1107 | 0.140 |
Why?
|
Esophageal Fistula | 1 | 2017 | 59 | 0.140 |
Why?
|
Patient Care Management | 1 | 2020 | 297 | 0.140 |
Why?
|
Stenotrophomonas maltophilia | 1 | 2016 | 17 | 0.140 |
Why?
|
Metapneumovirus | 1 | 2016 | 28 | 0.140 |
Why?
|
Peanut Hypersensitivity | 1 | 2019 | 212 | 0.140 |
Why?
|
Biopsy | 3 | 2019 | 6732 | 0.140 |
Why?
|
Computer Systems | 1 | 2018 | 471 | 0.140 |
Why?
|
Echocardiography | 2 | 2020 | 4909 | 0.140 |
Why?
|
Home Care Services, Hospital-Based | 1 | 2016 | 43 | 0.140 |
Why?
|
Health Status Indicators | 2 | 2019 | 959 | 0.140 |
Why?
|
Paramyxoviridae Infections | 1 | 2016 | 57 | 0.140 |
Why?
|
Sigmoid Diseases | 1 | 2016 | 57 | 0.140 |
Why?
|
Assisted Circulation | 1 | 2016 | 102 | 0.130 |
Why?
|
Toes | 1 | 2017 | 208 | 0.130 |
Why?
|
Drug Resistance, Microbial | 1 | 2019 | 851 | 0.130 |
Why?
|
Recurrence | 3 | 2020 | 8373 | 0.130 |
Why?
|
Metagenomics | 2 | 2017 | 436 | 0.130 |
Why?
|
Fatal Outcome | 2 | 2017 | 1825 | 0.130 |
Why?
|
Anthropometry | 2 | 2010 | 1338 | 0.130 |
Why?
|
Annual Reports as Topic | 2 | 2011 | 35 | 0.130 |
Why?
|
Fistula | 1 | 2017 | 213 | 0.130 |
Why?
|
Aged | 29 | 2022 | 164222 | 0.130 |
Why?
|
Radionuclide Imaging | 2 | 2019 | 1978 | 0.120 |
Why?
|
Diverticulitis, Colonic | 1 | 2016 | 129 | 0.120 |
Why?
|
Drainage, Postural | 1 | 2014 | 2 | 0.120 |
Why?
|
Coronary Artery Disease | 1 | 2015 | 6456 | 0.120 |
Why?
|
Enterovirus | 1 | 2015 | 64 | 0.120 |
Why?
|
Osteoporosis | 2 | 2019 | 1581 | 0.120 |
Why?
|
Enterovirus Infections | 1 | 2015 | 71 | 0.120 |
Why?
|
Motivation | 2 | 2021 | 1963 | 0.120 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2008 | 2190 | 0.120 |
Why?
|
Cohort Studies | 9 | 2022 | 40505 | 0.120 |
Why?
|
Constipation | 1 | 2019 | 549 | 0.120 |
Why?
|
Exercise Therapy | 2 | 2018 | 904 | 0.120 |
Why?
|
Prevalence | 7 | 2016 | 15306 | 0.110 |
Why?
|
Metagenome | 1 | 2017 | 423 | 0.110 |
Why?
|
Acute Kidney Injury | 1 | 2006 | 1841 | 0.110 |
Why?
|
Disease Progression | 4 | 2020 | 13302 | 0.110 |
Why?
|
Fluoroquinolones | 1 | 2015 | 305 | 0.110 |
Why?
|
Cytokines | 2 | 2019 | 7219 | 0.110 |
Why?
|
Hospitals, University | 1 | 2015 | 566 | 0.110 |
Why?
|
Pneumonia, Bacterial | 1 | 2016 | 316 | 0.110 |
Why?
|
Immunologic Factors | 2 | 2014 | 1568 | 0.110 |
Why?
|
Respiratory System | 1 | 2016 | 552 | 0.110 |
Why?
|
Tobacco Use Disorder | 1 | 2019 | 695 | 0.110 |
Why?
|
Cause of Death | 4 | 2011 | 3615 | 0.110 |
Why?
|
Homozygote | 1 | 2018 | 1767 | 0.110 |
Why?
|
Incidence | 7 | 2018 | 20812 | 0.110 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 3 | 2018 | 3136 | 0.110 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2021 | 991 | 0.110 |
Why?
|
Syndrome | 2 | 2017 | 3245 | 0.110 |
Why?
|
HLA Antigens | 1 | 2018 | 1340 | 0.110 |
Why?
|
Pericardium | 1 | 2017 | 666 | 0.100 |
Why?
|
Respiratory Tract Diseases | 1 | 2018 | 740 | 0.100 |
Why?
|
Drug Combinations | 1 | 2018 | 1957 | 0.100 |
Why?
|
Pneumonectomy | 2 | 2017 | 1107 | 0.100 |
Why?
|
Emphysema | 1 | 2015 | 237 | 0.100 |
Why?
|
Stress, Psychological | 2 | 2019 | 4287 | 0.100 |
Why?
|
Mycophenolic Acid | 1 | 2014 | 333 | 0.100 |
Why?
|
International Cooperation | 2 | 2016 | 1416 | 0.100 |
Why?
|
Leg | 1 | 2017 | 1086 | 0.100 |
Why?
|
Practice Guidelines as Topic | 2 | 2012 | 7272 | 0.100 |
Why?
|
Age Distribution | 3 | 2011 | 2842 | 0.100 |
Why?
|
Photosensitivity Disorders | 1 | 2011 | 80 | 0.100 |
Why?
|
Organ Size | 3 | 2013 | 2239 | 0.100 |
Why?
|
Liver | 2 | 2017 | 7371 | 0.100 |
Why?
|
Hypolipidemic Agents | 1 | 2015 | 612 | 0.090 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2015 | 991 | 0.090 |
Why?
|
Intracranial Hemorrhages | 1 | 2017 | 836 | 0.090 |
Why?
|
Cryopreservation | 1 | 2016 | 700 | 0.090 |
Why?
|
Treatment Failure | 1 | 2017 | 2614 | 0.090 |
Why?
|
Spirometry | 3 | 2018 | 903 | 0.090 |
Why?
|
Algorithms | 2 | 2024 | 13798 | 0.090 |
Why?
|
Physical Therapy Modalities | 1 | 2014 | 526 | 0.090 |
Why?
|
Forced Expiratory Flow Rates | 1 | 2010 | 75 | 0.090 |
Why?
|
B-Lymphocytes | 1 | 2024 | 4671 | 0.090 |
Why?
|
Pseudomonas Infections | 2 | 2012 | 614 | 0.090 |
Why?
|
Influenza A virus | 1 | 2014 | 452 | 0.090 |
Why?
|
Decision Support Techniques | 2 | 2017 | 1958 | 0.090 |
Why?
|
Hydrocephalus | 1 | 2017 | 752 | 0.090 |
Why?
|
Shock, Septic | 1 | 2017 | 765 | 0.090 |
Why?
|
Anti-Infective Agents | 3 | 2013 | 972 | 0.090 |
Why?
|
DNA, Bacterial | 1 | 2015 | 1439 | 0.090 |
Why?
|
Cross-Sectional Studies | 2 | 2021 | 25174 | 0.090 |
Why?
|
Paranasal Sinuses | 1 | 2012 | 263 | 0.090 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2572 | 0.090 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2016 | 597 | 0.080 |
Why?
|
Ciprofloxacin | 1 | 2011 | 308 | 0.080 |
Why?
|
Chi-Square Distribution | 1 | 2015 | 3426 | 0.080 |
Why?
|
Stem Cell Transplantation | 1 | 2018 | 1597 | 0.080 |
Why?
|
Critical Care | 2 | 2020 | 2662 | 0.080 |
Why?
|
Pediatrics | 2 | 2014 | 3559 | 0.080 |
Why?
|
Intensive Care Units | 2 | 2020 | 3669 | 0.080 |
Why?
|
Antibiotic Prophylaxis | 1 | 2014 | 628 | 0.080 |
Why?
|
Polymerase Chain Reaction | 2 | 2016 | 6058 | 0.080 |
Why?
|
Cytomegalovirus Infections | 1 | 2015 | 823 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 3 | 2018 | 20145 | 0.080 |
Why?
|
United States | 5 | 2023 | 70368 | 0.080 |
Why?
|
Sex Factors | 2 | 2020 | 10278 | 0.080 |
Why?
|
Heart Ventricles | 1 | 2020 | 3772 | 0.080 |
Why?
|
Vitamin K Deficiency | 1 | 2008 | 25 | 0.080 |
Why?
|
Rodentia | 1 | 2009 | 259 | 0.080 |
Why?
|
Ischemia | 1 | 2017 | 1857 | 0.080 |
Why?
|
Cross-Over Studies | 3 | 2018 | 2011 | 0.080 |
Why?
|
Reference Values | 3 | 2011 | 4875 | 0.070 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2012 | 346 | 0.070 |
Why?
|
Tissue Adhesions | 1 | 2009 | 228 | 0.070 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2015 | 950 | 0.070 |
Why?
|
Intestine, Small | 1 | 2013 | 1186 | 0.070 |
Why?
|
Affective Symptoms | 1 | 2010 | 409 | 0.070 |
Why?
|
Osteocalcin | 1 | 2008 | 270 | 0.070 |
Why?
|
Smoking Cessation | 1 | 2019 | 2069 | 0.070 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2011 | 443 | 0.070 |
Why?
|
Living Donors | 1 | 2011 | 612 | 0.070 |
Why?
|
Sirolimus | 1 | 2014 | 1529 | 0.070 |
Why?
|
Death | 2 | 2022 | 665 | 0.070 |
Why?
|
Disease Management | 1 | 2017 | 2451 | 0.070 |
Why?
|
Bacteria | 1 | 2017 | 2136 | 0.070 |
Why?
|
Oxygen | 1 | 2018 | 4175 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3610 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2016 | 2188 | 0.070 |
Why?
|
Communication | 1 | 2020 | 3783 | 0.070 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2010 | 653 | 0.070 |
Why?
|
Bone Marrow | 1 | 2016 | 2901 | 0.060 |
Why?
|
Bronchi | 1 | 2009 | 842 | 0.060 |
Why?
|
Adrenal Cortex Hormones | 1 | 2014 | 1867 | 0.060 |
Why?
|
Kidney Failure, Chronic | 1 | 2017 | 2448 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2020 | 3896 | 0.060 |
Why?
|
Diabetes Mellitus | 2 | 2015 | 5765 | 0.060 |
Why?
|
London | 1 | 2005 | 233 | 0.060 |
Why?
|
Tacrolimus | 1 | 2008 | 717 | 0.060 |
Why?
|
Peritoneal Dialysis | 1 | 2006 | 145 | 0.060 |
Why?
|
Logistic Models | 2 | 2019 | 13164 | 0.060 |
Why?
|
Bone Marrow Transplantation | 1 | 2012 | 2676 | 0.060 |
Why?
|
Resource Allocation | 2 | 2018 | 339 | 0.060 |
Why?
|
Fundoplication | 1 | 2005 | 144 | 0.060 |
Why?
|
Lymph Nodes | 1 | 2016 | 3446 | 0.060 |
Why?
|
Acute Disease | 2 | 2016 | 7116 | 0.060 |
Why?
|
Gastrointestinal Diseases | 1 | 2012 | 1169 | 0.060 |
Why?
|
Anxiety | 1 | 2018 | 4401 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3642 | 0.060 |
Why?
|
Influenza Vaccines | 1 | 2011 | 745 | 0.060 |
Why?
|
Mood Disorders | 1 | 2010 | 1103 | 0.060 |
Why?
|
Odds Ratio | 1 | 2015 | 9596 | 0.060 |
Why?
|
Genotype | 1 | 2018 | 12775 | 0.060 |
Why?
|
Immunohistochemistry | 1 | 2017 | 11037 | 0.060 |
Why?
|
Hospitals | 1 | 2017 | 3852 | 0.050 |
Why?
|
Creatinine | 1 | 2008 | 1848 | 0.050 |
Why?
|
Prospective Studies | 5 | 2020 | 53219 | 0.050 |
Why?
|
Isoantibodies | 2 | 2017 | 638 | 0.050 |
Why?
|
Air Pollution | 1 | 2017 | 2288 | 0.050 |
Why?
|
Models, Animal | 1 | 2009 | 2111 | 0.050 |
Why?
|
Drug Therapy, Combination | 2 | 2014 | 6459 | 0.050 |
Why?
|
Kidney Transplantation | 1 | 2017 | 4091 | 0.050 |
Why?
|
Kidney | 1 | 2017 | 6984 | 0.050 |
Why?
|
Cytomegalovirus | 2 | 2018 | 747 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8509 | 0.050 |
Why?
|
Canada | 1 | 2007 | 2088 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 2 | 2020 | 35781 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2017 | 4315 | 0.050 |
Why?
|
Intraoperative Complications | 1 | 2009 | 1178 | 0.050 |
Why?
|
Insulin | 1 | 2016 | 6470 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2014 | 3542 | 0.050 |
Why?
|
Data Interpretation, Statistical | 2 | 2008 | 2685 | 0.050 |
Why?
|
Body Composition | 1 | 2010 | 2381 | 0.050 |
Why?
|
Reproducibility of Results | 4 | 2019 | 19804 | 0.050 |
Why?
|
Bone Density | 2 | 2019 | 3510 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2009 | 4858 | 0.050 |
Why?
|
Hematologic Neoplasms | 1 | 2012 | 1837 | 0.050 |
Why?
|
Glomerular Filtration Rate | 1 | 2008 | 2142 | 0.050 |
Why?
|
Radiography | 2 | 2017 | 6939 | 0.050 |
Why?
|
Bone Remodeling | 2 | 2019 | 578 | 0.050 |
Why?
|
Communicable Diseases | 1 | 2009 | 869 | 0.050 |
Why?
|
Predictive Value of Tests | 4 | 2016 | 15010 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 10095 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2005 | 1065 | 0.040 |
Why?
|
Case-Control Studies | 5 | 2018 | 21676 | 0.040 |
Why?
|
Swine | 1 | 2009 | 5869 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 6420 | 0.040 |
Why?
|
Self Care | 2 | 2016 | 777 | 0.040 |
Why?
|
Observer Variation | 1 | 2005 | 2574 | 0.040 |
Why?
|
Vaccines | 1 | 2007 | 817 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12839 | 0.040 |
Why?
|
Infusions, Intravenous | 2 | 2016 | 2206 | 0.040 |
Why?
|
Risk | 1 | 2011 | 9521 | 0.040 |
Why?
|
Viscoelastic Substances | 1 | 2018 | 20 | 0.040 |
Why?
|
Thyroid Function Tests | 1 | 2019 | 289 | 0.040 |
Why?
|
Qualitative Research | 2 | 2018 | 2840 | 0.040 |
Why?
|
Mucociliary Clearance | 1 | 2018 | 80 | 0.040 |
Why?
|
Parathyroid Hormone | 2 | 2019 | 1781 | 0.040 |
Why?
|
Viscosity | 1 | 2018 | 322 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2015 | 6300 | 0.040 |
Why?
|
Pancreatic Neoplasms | 1 | 2015 | 5261 | 0.040 |
Why?
|
Regression Analysis | 2 | 2018 | 6332 | 0.040 |
Why?
|
Herpesvirus 7, Human | 1 | 2017 | 14 | 0.040 |
Why?
|
Gastrointestinal Motility | 1 | 2019 | 226 | 0.040 |
Why?
|
Torque teno virus | 1 | 2017 | 13 | 0.040 |
Why?
|
Parainfluenza Virus 3, Human | 1 | 1997 | 25 | 0.040 |
Why?
|
Respirovirus Infections | 1 | 1997 | 52 | 0.040 |
Why?
|
Models, Biological | 2 | 2010 | 9443 | 0.040 |
Why?
|
Histocompatibility | 1 | 2018 | 312 | 0.040 |
Why?
|
Rheology | 1 | 2018 | 345 | 0.040 |
Why?
|
Roseolovirus Infections | 1 | 2017 | 48 | 0.040 |
Why?
|
Inflammation | 1 | 2016 | 10591 | 0.040 |
Why?
|
Mutation | 2 | 2019 | 29620 | 0.030 |
Why?
|
Histocompatibility Testing | 1 | 2018 | 695 | 0.030 |
Why?
|
Interleukin-8 | 1 | 2019 | 690 | 0.030 |
Why?
|
Colostomy | 1 | 2016 | 102 | 0.030 |
Why?
|
Elasticity | 1 | 2018 | 651 | 0.030 |
Why?
|
Picornaviridae Infections | 1 | 2017 | 90 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5689 | 0.030 |
Why?
|
Ileostomy | 1 | 2016 | 117 | 0.030 |
Why?
|
Rhinovirus | 1 | 2017 | 195 | 0.030 |
Why?
|
Macrolides | 1 | 2017 | 204 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2013 | 17831 | 0.030 |
Why?
|
Intestinal Obstruction | 1 | 2019 | 431 | 0.030 |
Why?
|
Muscle Strength | 1 | 2019 | 599 | 0.030 |
Why?
|
Respiratory Hypersensitivity | 1 | 1997 | 266 | 0.030 |
Why?
|
Withholding Treatment | 1 | 2019 | 602 | 0.030 |
Why?
|
Heart Defects, Congenital | 1 | 2011 | 4657 | 0.030 |
Why?
|
Patient Education as Topic | 2 | 2016 | 2278 | 0.030 |
Why?
|
Transplants | 1 | 2017 | 205 | 0.030 |
Why?
|
Acetylcholine | 1 | 1997 | 627 | 0.030 |
Why?
|
Fungi | 1 | 2017 | 328 | 0.030 |
Why?
|
Intestinal Perforation | 1 | 2016 | 252 | 0.030 |
Why?
|
Limb Salvage | 1 | 2017 | 458 | 0.030 |
Why?
|
Signal Transduction | 1 | 2017 | 23115 | 0.030 |
Why?
|
Carbon Monoxide | 1 | 2017 | 540 | 0.030 |
Why?
|
Rats, Inbred BN | 1 | 2013 | 194 | 0.030 |
Why?
|
Sex Distribution | 1 | 2019 | 2258 | 0.030 |
Why?
|
Netherlands | 1 | 2018 | 2180 | 0.030 |
Why?
|
Nasopharynx | 1 | 2016 | 388 | 0.030 |
Why?
|
Transplantation, Heterotopic | 1 | 2013 | 169 | 0.030 |
Why?
|
Genome, Viral | 1 | 2017 | 663 | 0.030 |
Why?
|
Immunoglobulin E | 1 | 2019 | 1491 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2019 | 2841 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2016 | 1152 | 0.030 |
Why?
|
Nasal Lavage | 1 | 2012 | 16 | 0.030 |
Why?
|
Muscle Weakness | 1 | 2015 | 409 | 0.030 |
Why?
|
Necrosis | 1 | 2017 | 1593 | 0.030 |
Why?
|
Advance Care Planning | 1 | 2020 | 676 | 0.030 |
Why?
|
Aspergillosis | 1 | 2014 | 244 | 0.030 |
Why?
|
Monitoring, Immunologic | 1 | 2012 | 95 | 0.030 |
Why?
|
Sampling Studies | 1 | 2013 | 617 | 0.030 |
Why?
|
Macrophages | 2 | 2017 | 5648 | 0.030 |
Why?
|
Rats, Inbred Lew | 1 | 2013 | 1080 | 0.020 |
Why?
|
Candidiasis | 1 | 2014 | 357 | 0.020 |
Why?
|
Colectomy | 1 | 2016 | 668 | 0.020 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2012 | 166 | 0.020 |
Why?
|
Perception | 1 | 2018 | 1175 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2016 | 1679 | 0.020 |
Why?
|
Chills | 1 | 2010 | 17 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2018 | 14114 | 0.020 |
Why?
|
Muscle Cramp | 1 | 2010 | 33 | 0.020 |
Why?
|
Heart-Assist Devices | 2 | 2011 | 1243 | 0.020 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2011 | 111 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2019 | 3134 | 0.020 |
Why?
|
Body Fluid Compartments | 1 | 2010 | 50 | 0.020 |
Why?
|
Propensity Score | 1 | 2018 | 1848 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2013 | 1710 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14537 | 0.020 |
Why?
|
ROC Curve | 1 | 2018 | 3496 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2016 | 1872 | 0.020 |
Why?
|
Intraoperative Care | 1 | 2013 | 748 | 0.020 |
Why?
|
Expectorants | 1 | 2009 | 19 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2017 | 1710 | 0.020 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2010 | 275 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2019 | 3153 | 0.020 |
Why?
|
Animals | 5 | 2017 | 166308 | 0.020 |
Why?
|
Cadaver | 1 | 2013 | 1334 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2013 | 2473 | 0.020 |
Why?
|
Drug Resistance, Bacterial | 1 | 2016 | 1024 | 0.020 |
Why?
|
Deoxyribonuclease I | 1 | 2009 | 223 | 0.020 |
Why?
|
Length of Stay | 2 | 2012 | 6292 | 0.020 |
Why?
|
Wakefulness | 1 | 2015 | 1240 | 0.020 |
Why?
|
25-Hydroxyvitamin D 2 | 1 | 2008 | 39 | 0.020 |
Why?
|
Leukocytes | 1 | 2016 | 2010 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2019 | 4335 | 0.020 |
Why?
|
Drug Substitution | 1 | 2010 | 284 | 0.020 |
Why?
|
Virus Replication | 1 | 2015 | 2452 | 0.020 |
Why?
|
Nausea | 1 | 2010 | 668 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2016 | 10719 | 0.020 |
Why?
|
Vomiting | 1 | 2010 | 629 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2018 | 3075 | 0.020 |
Why?
|
Fibroblasts | 1 | 2017 | 4039 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2014 | 2416 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2012 | 15306 | 0.020 |
Why?
|
Fibrosis | 1 | 2013 | 2005 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8370 | 0.020 |
Why?
|
Physical Endurance | 1 | 2009 | 360 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4576 | 0.020 |
Why?
|
Pulmonary Emphysema | 1 | 2011 | 678 | 0.020 |
Why?
|
Critical Illness | 1 | 2019 | 2690 | 0.020 |
Why?
|
Contrast Media | 1 | 2019 | 5251 | 0.020 |
Why?
|
Blotting, Western | 1 | 2013 | 5048 | 0.020 |
Why?
|
Emergencies | 1 | 2012 | 1166 | 0.020 |
Why?
|
Peripheral Arterial Disease | 1 | 2017 | 1255 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2015 | 5982 | 0.020 |
Why?
|
Particulate Matter | 1 | 2017 | 2518 | 0.020 |
Why?
|
Vitamin D | 1 | 2019 | 3239 | 0.020 |
Why?
|
Collagen | 1 | 2013 | 2616 | 0.020 |
Why?
|
Palliative Care | 1 | 2020 | 3546 | 0.020 |
Why?
|
Health Care Rationing | 1 | 2008 | 429 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2018 | 4010 | 0.020 |
Why?
|
Hypotension | 1 | 2010 | 863 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3058 | 0.010 |
Why?
|
Physical Fitness | 1 | 2009 | 723 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2244 | 0.010 |
Why?
|
Health Status | 1 | 2017 | 4016 | 0.010 |
Why?
|
Sepsis | 1 | 2018 | 2589 | 0.010 |
Why?
|
Air Pollutants | 1 | 2017 | 2806 | 0.010 |
Why?
|
Fever | 1 | 2010 | 1604 | 0.010 |
Why?
|
Headache | 1 | 2010 | 1223 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2012 | 6781 | 0.010 |
Why?
|
Pseudomonas aeruginosa | 1 | 2009 | 1227 | 0.010 |
Why?
|
Absorptiometry, Photon | 1 | 2008 | 1730 | 0.010 |
Why?
|
Pneumonia | 1 | 2013 | 2110 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2015 | 4863 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16250 | 0.010 |
Why?
|
Graft vs Host Disease | 1 | 2012 | 2931 | 0.010 |
Why?
|
Cardiomyopathies | 1 | 2011 | 1898 | 0.010 |
Why?
|
Recovery of Function | 1 | 2010 | 2924 | 0.010 |
Why?
|
Adipose Tissue | 1 | 2010 | 3258 | 0.010 |
Why?
|
Survivors | 1 | 2009 | 2302 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2013 | 12742 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 7812 | 0.010 |
Why?
|
Rats | 1 | 2013 | 23681 | 0.010 |
Why?
|
Blood Glucose | 1 | 2011 | 6213 | 0.010 |
Why?
|
Bronchial Provocation Tests | 1 | 1997 | 218 | 0.010 |
Why?
|
Capsaicin | 1 | 1997 | 226 | 0.010 |
Why?
|
Airway Resistance | 1 | 1997 | 402 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1997 | 1315 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 1997 | 1140 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2012 | 7699 | 0.010 |
Why?
|
Microscopy | 1 | 1997 | 879 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2014 | 13531 | 0.010 |
Why?
|
Neuropeptides | 1 | 1997 | 941 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1997 | 6220 | 0.000 |
Why?
|